157 related articles for article (PubMed ID: 27403783)
21. Appropriate migraine therapy for children and adolescents.
Farkas V
Cephalalgia; 1999 Mar; 19 Suppl 23():24-6; discussion 26-8. PubMed ID: 10099852
[No Abstract] [Full Text] [Related]
22. Sumatriptan iontophoretic transdermal system: history, study results, and use in clinical practice.
Pierce M; O'Neill C; Felker E; Sebree T
Headache; 2013 Sep; 53 Suppl 2():34-42. PubMed ID: 24024601
[TBL] [Abstract][Full Text] [Related]
23. Sumatriptan iontophoretic patch for migraine.
Tepper DE
Headache; 2014 Oct; 54(9):1563-4. PubMed ID: 25324166
[No Abstract] [Full Text] [Related]
24. A pharmacokinetic interaction study between butorphanol and sumatriptan nasal sprays in healthy subjects: importance of the timing of butorphanol administration.
Vachharajani NN; Shyu WC; Nichola PS; Boulton DW
Cephalalgia; 2002 May; 22(4):282-7. PubMed ID: 12100090
[TBL] [Abstract][Full Text] [Related]
25. Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience.
Welch KM
Cephalalgia; 2001; 21 Suppl 1():25-8. PubMed ID: 11678818
[No Abstract] [Full Text] [Related]
26. [Therapy of severe migraine attacks: practical tips].
Göbel H
MMW Fortschr Med; 2005 May; 147 Spec No 2():21-2, 24-6. PubMed ID: 15968868
[TBL] [Abstract][Full Text] [Related]
27. Improved pharmacokinetics of sumatriptan with Breath Powered™ nasal delivery of sumatriptan powder.
Obaidi M; Offman E; Messina J; Carothers J; Djupesland PG; Mahmoud RA
Headache; 2013 Sep; 53(8):1323-33. PubMed ID: 23992438
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients.
Sternieri E; Pinetti D; Coccia CP; Leone S; Bertolini A; Ferrari A
J Headache Pain; 2005 Sep; 6(4):319-21. PubMed ID: 16362699
[TBL] [Abstract][Full Text] [Related]
29. Sumatriptan-induced chest symptoms in Japanese.
Hirata K
Intern Med; 2002 Aug; 41(8):599-600. PubMed ID: 12211521
[No Abstract] [Full Text] [Related]
30. Nasal sumatriptan: new dosage. For adolescents with migraine: too little benefit.
Prescrire Int; 2005 Apr; 14(76):45-7. PubMed ID: 15875337
[TBL] [Abstract][Full Text] [Related]
31. Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine.
Tfelt-Hansen P; Hougaard A
Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):91-103. PubMed ID: 23228070
[TBL] [Abstract][Full Text] [Related]
32. A unique iontophoretic patch for optimal transdermal delivery of sumatriptan.
Siegel SJ; O'Neill C; Dubé LM; Kaldeway P; Morris R; Jackson D; Sebree T
Pharm Res; 2007 Oct; 24(10):1919-26. PubMed ID: 17577644
[TBL] [Abstract][Full Text] [Related]
33. A Randomized Trial of Ketorolac vs. Sumatripan vs. Placebo Nasal Spray (KSPN) for Acute Migraine.
Rao AS; Gelaye B; Kurth T; Dash PD; Nitchie H; Peterlin BL
Headache; 2016 Feb; 56(2):331-40. PubMed ID: 26840902
[TBL] [Abstract][Full Text] [Related]
34. A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients.
Gutman D; Hellriegel E; Aycardi E; Bigal ME; Kunta J; Chitra R; Kansagra S; Kidron OS; Knebel H; Linder S; Ma Y; Pierce M; Winner PK; Spiegelstein O
Headache; 2016 Sep; 56(8):1300-9. PubMed ID: 27474357
[TBL] [Abstract][Full Text] [Related]
35. Primary care in a health maintenance organization.
Cady R
Cephalalgia; 1999 Jul; 19(6):541-2. PubMed ID: 10523121
[No Abstract] [Full Text] [Related]
36. Vasospasm-induced myocardial infarction with sumatriptan.
Mueller L; Gallagher RM; Ciervo CA
Headache; 1996 May; 36(5):329-31. PubMed ID: 8682677
[TBL] [Abstract][Full Text] [Related]
37. Where do triptans act in the treatment of migraine?
Ahn AH; Basbaum AI
Pain; 2005 May; 115(1-2):1-4. PubMed ID: 15836963
[No Abstract] [Full Text] [Related]
38. Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration.
Duquesnoy C; Mamet JP; Sumner D; Fuseau E
Eur J Pharm Sci; 1998 Apr; 6(2):99-104. PubMed ID: 9795022
[TBL] [Abstract][Full Text] [Related]
39. Sumatriptan succinate loaded chitosan solid lipid nanoparticles for enhanced anti-migraine potential.
Hansraj GP; Singh SK; Kumar P
Int J Biol Macromol; 2015 Nov; 81():467-76. PubMed ID: 26299709
[TBL] [Abstract][Full Text] [Related]
40. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines.
Allena M; Magis D; Schoenen J
Neurology; 2005 Oct; 65(8):1339-40; author reply 1339-40. PubMed ID: 16250085
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
